Patients who received a CGM had significantly fewer comorbidity claims for all comorbidities except Chronic Kidney Disease, where CGM patients were slightly more likely to have an associated claim than non-CGM patients (13.7% v 10.8%) Hypertension was the commonly reported comorbidity among patients who received a CGM (36.6%), but patients without a CGM still had a far higher rate of associated hypertension claims (83.6%)
Eli Lilly is expected to publish results in 2026
Blurred vision or floaters are sometimes reported early in treatment
However, it carries risks of liver toxicity, gallbladder side effects, and potential drug interactions, particularly with statins 120,121
Phospholipids of Lipoprotein Particles Lipoprotein particles possess a monolayer of phospholipids that cover the surface of the particles
Surgical Procedures Are Increasingly Imperiled by New Pharmaceuticals September 8, 2025 Study Takeaways As new therapies enter the market and emerging clinical evidence reshapes physician practice patterns, the prevailing procedure-based approach to care will change